| scholarly article | Q13442814 |
| P50 | author | Jonas Bystrom | Q89613853 |
| P2093 | author name string | Kawa Amin | |
| Taher E Taher | |||
| Ali Hattem | |||
| Aram H Rasool | |||
| Taha Am Al-Karboly | |||
| P2860 | cites work | Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. | Q43041939 |
| Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis | Q44086661 | ||
| Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population | Q44177422 | ||
| Simplified criteria for the diagnosis of autoimmune hepatitis | Q44425899 | ||
| Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity | Q44624737 | ||
| Differentiation between autoimmune hepatitis and hepatitis C virus related liver disease | Q44759642 | ||
| Histological findings in chronic hepatitis C with autoimmune features | Q45162387 | ||
| Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter? | Q45511165 | ||
| Liver/kidney microsome antibody type 1 and hepatitis C virus infection | Q45872748 | ||
| Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. | Q46034647 | ||
| Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis. | Q46073027 | ||
| Autoantibody profile in individuals with chronic hepatitis C. | Q50933723 | ||
| Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? | Q53175499 | ||
| Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C-related chronic liver disease in Sweden. Swedish Internal Medicine Liver club | Q73113401 | ||
| HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients | Q80352996 | ||
| Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group | Q80820259 | ||
| Autoimmune liver serology: current diagnostic and clinical challenges | Q24644140 | ||
| Low prevalence of liver-kidney microsomal autoantibodies of type 1 (LKM1) in hepatitis C seropositive subjects on Crete, Greece | Q24799970 | ||
| Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection | Q27480424 | ||
| Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. | Q30846833 | ||
| Autoimmunity and extrahepatic manifestations in hepatitis C virus infection | Q33809432 | ||
| Autoantibodies and liver disease: uses and abuses. | Q33829963 | ||
| Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management | Q33977201 | ||
| Is autoimmune hepatitis a frequent finding among HCV patients with intense interface hepatitis? | Q34041429 | ||
| Proinflammatory T helper type 17 cells are effective B-cell helpers | Q34069686 | ||
| Diagnosis and management of autoimmune hepatitis | Q34118165 | ||
| LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase | Q34205552 | ||
| Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile | Q34439843 | ||
| Clinical significance of antinuclear antibodies. Comparison of detection with immunofluorescence and enzyme‐linked immunosorbent assays | Q34441511 | ||
| Cell damage and autoimmunity: a critical appraisal | Q36440448 | ||
| Nature and functions of autoantibodies | Q37243935 | ||
| Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders. | Q37654478 | ||
| Infections and autoimmunity: the multifaceted relationship | Q37656876 | ||
| CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver | Q37714863 | ||
| Infectious diseases and autoimmunity | Q37945549 | ||
| Autoantibody-Negative Autoimmune Hepatitis | Q37970311 | ||
| Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis | Q38497449 | ||
| Harnessing the Therapeutic Potential of Th17 Cells | Q38535119 | ||
| Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance | Q39615584 | ||
| A 50-year experience with autoimmune hepatitis: and where are we now? | Q39818050 | ||
| Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. | Q40306312 | ||
| Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels | Q42550805 | ||
| Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection | Q42980744 | ||
| Non-organ-specific autoantibodies in children with chronic hepatitis C virus infection | Q42985121 | ||
| Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity | Q42985404 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoantibody | Q785022 |
| autoimmune hepatitis | Q786844 | ||
| chronic hepatitis C | Q55779873 | ||
| chronic hepatitis | Q62019625 | ||
| P304 | page(s) | 1345-1352 | |
| P577 | publication date | 2017-02-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease | |
| P478 | volume | 23 |
Search more.